Cargando…
Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19
BACKGROUND: Coronavirus disease-2019 (COVID-19) is a global pandemic. Obesity has been associated with increased disease severity in COVID-19, and obesity is strongly associated with hepatic steatosis (HS). However, how HS alters the natural history of COVID-19 is not well characterized, especially...
Autores principales: | Chen, Vincent L., Hawa, Fadi, Berinstein, Jeffrey A., Reddy, Chanakyaram A., Kassab, Ihab, Platt, Kevin D., Hsu, Chia-Yang, Steiner, Calen A., Louissaint, Jeremy, Gunaratnam, Naresh T., Sharma, Pratima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520076/ https://www.ncbi.nlm.nih.gov/pubmed/32980956 http://dx.doi.org/10.1007/s10620-020-06618-3 |
Ejemplares similares
-
Effective Treatment of Nonalcoholic Fatty Liver Disease Using a Community-Based Weight Management Program
por: Hawa, Fadi, et al.
Publicado: (2021) -
Pill or procedure? Patient preferences on beta-blockers as an alternative to endoscopic variceal screening during the COVID-19 pandemic
por: Che, Zheng, et al.
Publicado: (2022) -
Endoscopic Management of a Tubulovillous Adenoma Within a Diverticulum: Report of a Case and Review of Literature
por: Hawa, Fadi, et al.
Publicado: (2020) -
Patients With Gastrointestinal Conditions Consider Telehealth Equivalent to In-Person Care
por: Dobrusin, Avi, et al.
Publicado: (2023) -
Gastroenterologists and Patients Report High Satisfaction Rates With Telehealth Services During the Novel Coronavirus 2019 Pandemic
por: Dobrusin, Avi, et al.
Publicado: (2020)